Medicines Act 1968 (c. 67)

Part III U.K. Further Provisions relating to Dealings with Medicinal Products

Modifications etc. (not altering text)

C1 Part III (ss.51-68) modified (1.1.1995) by S.I. 1994/3144, reg. 9(9)

C2 Pt. III amendment to earlier affecting provision SI 1994/3144 reg. 9 (30.10.2005) by Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005 (S.I. 2005/2759), regs. 1(a), 2(12)

Additional provisions U.K.

63 Adulteration of medicinal products. U.K.

No person shall—

(a) add any substance to, or abstract any substance from, a medicinal product so as to affect injuriously the composition of the product, with intent that the product shall be sold or supplied in that state, or

(b) sell or supply, or offer or expose for sale or supply, or have in his possession for the purpose of sale or supply, any medicinal product whose composition has been injuriously affected by the addition or abstraction of any substance.

Modifications etc. (not altering text)

C3 Ss. 63–65 extended by S.I. 1984/187, art. 2

C4 S. 63 applied (1.1.1995) by S.I 1994/3142, reg. 18(2)